Importance of Wnt signaling in the tumor stroma microenvironment

Current Cancer Drug Targets

Volumn 8, Issue 6, 2008, Pages 454-465

  Macheda, Maria L ^a   Stacker, Steven A ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cancer therapy; Ror2; RYK; Stroma; Wnt signaling

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; CALCIUM ION; CELL SURFACE RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOTOXIC AGENT; DICKKOPF PROTEIN; FRIZZLED PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; ROR2 PROTEIN; SMALL INTERFERING RNA; SOLUBLE FRIZZLED RELATED PROTEIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN; VITAMIN D RECEPTOR; WNT INHIBITORY FACTOR 1; WNT PROTEIN;

BREAST TUMOR; CANCER THERAPY; CELL INTERACTION; CELL TYPE; COLORECTAL CANCER; DRUG TARGETING; ENZYME INHIBITION; GENE MUTATION; LIGAND BINDING; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE C MYC; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STROMA; TUMOR CELL; TUMOR STROMAL CELL;

BETA CATENIN; GENES, MYC; HUMANS; NEOPLASMS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STROMAL CELLS; WNT PROTEINS;

EID: 51349113366     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800908785699324     Document Type: Review

References (136)

1. Garriock, R. J.; Warkman, A. S.; Meadows, S. M.; D'Agostino, S.; Krieg, P. A. Census of Vertebrate Wnt Genes: Isolation and Developmental Expression of Xenopus Wnt2, Wnt3, Wnt9a, Wnt9b, Wnt10a, and Wnt16. Dev. Dyn. 2007, 236, 1249-1258.
2. Willert, K.; Brown, J. D.; Danenberg, E.; Duncan, A. W.; Weissman, I. L.; Reya, T.; Yates, J. R., 3rd; Nusse, R. Wnt Proteins Are Lipid-Modified and Can Act as Stem Cell Growth Factors. Nature 2003, 423, 448-452.
3. Reichsman, F.; Smith, L.; Cumberledge, S. Glycosaminoglycans Can Modulate Extracellular Localization of the Wingless Protein and Promote Signal Transduction. J. Cell Biol. 1996, 135, 819-827.
4. Cadigan, K. M.; Liu, Y. I. Wnt Signaling: Complexity at the Surface. J. Cell Sci. 2006, 119, 395-402.
5. Hart, M. J.; de los Santos, R.; Albert, I. N.; Rubinfeld, B.; Polakis, P. Downregulation of Beta-Catenin by Human Axin and Its Association with the APC Tumor Suppressor, Beta-Catenin and GSK3 Beta. Curr. Biol. 1998, 8, 573-581.
6. Kishida, S.; Yamamoto, H.; Ikeda, S.; Kishida, M.; Sakamoto, I.; Koyama, S.; Kikuchi, A. Axin, a Negative Regulator of the Wnt Signaling Pathway, Directly Interacts with Adenomatous Polyposis Coli and Regulates the Stabilization of Beta-Catenin. J. Biol. Chem. 1998, 273, 10823-10826.
7. Amit, S.; Hatzubai, A.; Birman, Y.; Andersen, J. S.; Ben-Shushan, E.; Mann, M.; Ben-Neriah, Y.; Alkalay, I. Axin-Mediated CKI Phosphorylation of Beta-Catenin at Ser 45: A Molecular Switch for the Wnt Pathway. Genes Dev. 2002, 16, 1066-1076.
8. Kitagawa, M.; Hatakeyama, S.; Shirane, M.; Matsumoto, M.; Ishida, N.; Hattori, K.; Nakamichi, I.; Kikuchi, A.; Nakayama, K.; Nakayama, K. An F-Box Protein, FWD1, Mediates Ubiquitin-Dependent Proteolysis of Beta-Catenin. EMBO J. 1999, 18, 2401-2410.
9. Liu, C.; Kato, Y.; Zhang, Z.; Do, V. M.; Yankner, B. A.; He, X. Beta-Trcp Couples Beta-Catenin Phosphorylation-Degradation and Regulates Xenopus Axis Formation. Proc. Natl. Acad. Sci. USA 1999, 96, 6273-6278.
10. Lee, J. S.; Ishimoto, A.; Yanagawa, S. Characterization of Mouse Dishevelled (Dvl) Proteins in Wnt/Wingless Signaling Pathway. J. Biol. Chem. 1999, 274, 21464-21470.
11. Tamai, K.; Zeng, X.; Liu, C.; Zhang, X.; Harada, Y.; Chang, Z.; He, X. A Mechanism for Wnt Coreceptor Activation. Mol. Cell 2004, 13, 149-156.
12. Kohn, A. D.; Moon, R. T. Wnt and Calcium Signaling: Beta-Catenin- Independent Pathways. Cell Calcium 2005, 38, 439-446.
13. Habas, R.; Dawid, I. B.; He, X. Coactivation of Rac and Rho by Wnt/Frizzled Signaling Is Required for Vertebrate Gastrulation. Genes Dev. 2003, 17, 295-309.
14. Seifert, J. R.; Mlodzik, M. Frizzled/PCP Signalling: A Conserved Mechanism Regulating Cell Polarity and Directed Motility. Nat. Rev. Genet. 2007, 8, 126-138.
15. Heisenberg, C. P.; Tada, M.; Rauch, G. J.; Saude, L.; Concha, M. L.; Geisler, R.; Stemple, D. L.; Smith, J. C.; Wilson, S. W. Silberblick/Wnt11 Mediates Convergent Extension Movements During Zebrafish Gastrulation. Nature 2000, 405, 76-81.
16. Tada, M.; Smith, J. C. Xwnt11 Is a Target of Xenopus Brachyury: Regulation of Gastrulation Movements Via Dishevelled, but Not Through the Canonical Wnt Pathway. Development 2000, 127, 2227-2238.
17. Wallingford, J. B.; Rowning, B. A.; Vogeli, K. M.; Rothbacher, U.; Fraser, S. E.; Harland, R. M. Dishevelled Controls Cell Polarity During Xenopus Gastrulation. Nature 2000, 405, 81-85.
18. Dabdoub, A.; Donohue, M. J.; Brennan, A.; Wolf, V.; Montcouquiol, M.; Sassoon, D. A.; Hseih, J. C.; Rubin, J. S.; Salinas, P. C.; Kelley, M. W. Wnt Signaling Mediates Reorientation of Outer Hair Cell Stereociliary Bundles in the Mammalian Cochlea. Development 2003, 130, 2375-2384.
19. Leyns, L.; Bouwmeester, T.; Kim, S. H.; Piccolo, S.; De Robertis, E. M. Frzb-1 Is a Secreted Antagonist of Wnt Signaling Expressed in the Spemann Organizer. Cell 1997, 88, 747-756.
20. Mayr, T.; Deutsch, U.; Kuhl, M.; Drexler, H. C.; Lottspeich, F.; Deutzmann, R.; Wedlich, D.; Risau, W. Fritz: A Secreted Frizzled-Related Protein That Inhibits Wnt Activity. Mech. Dev. 1997, 63, 109-125.
21. Rattner, A.; Hsieh, J. C.; Smallwood, P. M.; Gilbert, D. J.; Copeland, N. G.; Jenkins, N. A.; Nathans, J. A Family of Secreted Proteins Contains Homology to the Cysteine-Rich Ligand-Binding Domain of Frizzled Receptors. Proc. Natl. Acad. Sci. USA 1997, 94, 2859-2863.
22. Wang, S.; Krinks, M.; Lin, K.; Luyten, F. P.; Moos, M., Jr. Frzb, a Secreted Protein Expressed in the Spemann Organizer, Binds and Inhibits Wnt-8. Cell 1997, 88, 757-766.
23. Hsieh, J. C.; Kodjabachian, L.; Rebbert, M. L.; Rattner, A.; Smallwood, P. M.; Samos, C. H.; Nusse, R.; Dawid, I. B.; Nathans, J. A New Secreted Protein That Binds to Wnt Proteins and Inhibits Their Activities. Nature 1999, 398, 431-436.
24. Glinka, A.; Wu, W.; Delius, H.; Monaghan, A. P.; Blumenstock, C.; Niehrs, C. Dickkopf-1 Is a Member of a New Family of Secreted Proteins and Functions in Head Induction. Nature 1998, 391, 357-362.
25. Krupnik, V. E.; Sharp, J. D.; Jiang, C.; Robison, K.; Chickering, T. W.; Amaravadi, L.; Brown, D. E.; Guyot, D.; Mays, G.; Leiby, K.; Chang, B.; Duong, T.; Goodearl, A. D.; Gearing, D. P.; Sokol, S. Y.; McCarthy, S. A. Functional and Structural Diversity of the Human Dickkopf Gene Family. Gene 1999, 238, 301-313.
26. Mao, B.; Wu, W.; Li, Y.; Hoppe, D.; Stannek, P.; Glinka, A.; Niehrs, C. LDL-Receptor-Related Protein 6 Is a Receptor for Dickkopf Proteins. Nature 2001, 411, 321-325.
27. Hoang, B. H.; Kubo, T.; Healey, J. H.; Yang, R.; Nathan, S. S.; Kolb, E. A.; Mazza, B.; Meyers, P. A.; Gorlick, R. Dickkopf 3 Inhibits Invasion and Motility of Saos-2 Osteosarcoma Cells by Modulating the Wnt-Beta-Catenin Pathway. Cancer Res. 2004, 64, 2734-2739.
28. Bafico, A.; Liu, G.; Yaniv, A.; Gazit, A.; Aaronson, S. A. Novel Mechanism of Wnt Signalling Inhibition Mediated by Dickkopf-1 Interaction with LRP6/Arrow. Nat. Cell Biol. 2001, 3, 683-686.
29. Semenov, M. V.; Tamai, K.; Brott, B. K.; Kuhl, M.; Sokol, S.; He, X. Head Inducer Dickkopf-1 Is a Ligand for Wnt Coreceptor LRP6. Curr. Biol. 2001, 11, 951-961.
30. Mao, B.; Wu, W.; Davidson, G.; Marhold, J.; Li, M.; Mechler, B. M.; Delius, H.; Hoppe, D.; Stannek, P.; Walter, C.; Glinka, A.; Niehrs, C. Kremen Proteins Are Dickkopf Receptors That Regulate Wnt/Beta-Catenin Signalling. Nature 2002, 417, 664-667.
31. Halford, M. M.; Stacker, S. A. Revelations of the RYK Receptor. Bioessays 2001, 23, 34-45.
32. Hovens, C. M.; Stacker, S. A.; Andres, A. C.; Harpur, A. G.; Ziemiecki, A.; Wilks, A. F. RYK, a Receptor Tyrosine Kinase-Related Molecule with Unusual Kinase Domain Motifs. Proc. Natl. Acad. Sci. USA 1992, 89, 11818-11822.
33. Wang, X. C.; Katso, R.; Butler, R.; Hanby, A. M.; Poulsom, R.; Jones, T.; Sheer, D.; Ganesan, T. S. H-RYK, an Unusual Receptor Kinase: Isolation and Analysis of Expression in Ovarian Cancer. Mol. Med. 1996, 2, 189-203.
34. Katso, R. M.; Russell, R. B.; Ganesan, T. S. Functional Analysis of H-Ryk, an Atypical Member of the Receptor Tyrosine Kinase Family. Mol. Cell. Biol. 1999, 19, 6427-6440.
35. Serfas, M. S.; Tyner, A. L. Ryk Is Expressed in a Differentiation- Specific Manner in Epithelial Tissues and Is Strongly Induced in Decidualizing Uterine Stroma. Oncogene 1998, 17, 3435-3444.
36. Inoue, T.; Oz, H. S.; Wiland, D.; Gharib, S.; Deshpande, R.; Hill, R. J.; Katz, W. S.; Sternberg, P. W. C. elegans LIN-18 Is a Ryk Ortholog and Functions in Parallel to LIN-17/Frizzled in Wnt Signaling. Cell 2004, 118, 795-806.
37. Callahan, C. A.; Muralidhar, M. G.; Lundgren, S. E.; Scully, A. L.; Thomas, J. B. Control of Neuronal Pathway Selection by a Drosophila Receptor Protein-Tyrosine Kinase Family Member. Nature 1995, 376, 171-174.
38. Oates, A. C.; Bonkovsky, J. L.; Irvine, D. V.; Kelly, L. E.; Thomas, J. B.; Wilks, A. F. Embryonic Expression and Activity of Doughnut, a Second RYK Homolog in Drosophila. Mech. Dev. 1998, 78, 165-169.
39. Moreau-Fauvarque, C.; Taillebourg, E.; Boissoneau, E.; Mesnard, J.; Dura, J. M. The Receptor Tyrosine Kinase Gene Linotte Is Required for Neuronal Pathway Selection in the Drosophila Mushroom Bodies. Mech. Dev. 1998, 78, 47-61.
40. Halford, M. M.; Armes, J.; Buchert, M.; Meskenaite, V.; Grail, D.; Hibbs, M. L.; Wilks, A. F.; Farlie, P. G.; Newgreen, D. F.; Hovens, C. M.; Stacker, S. A. RYK-Deficient Mice Exhibit Craniofacial Defects Associated with Perturbed Eph Receptor Crosstalk. Nat. Genet. 2000, 25, 414-418.
41. Keeble, T. R.; Halford, M. M.; Seaman, C.; Kee, N.; Macheda, M.; Anderson, R. B.; Stacker, S. A.; Cooper, H. M. The Wnt Receptor Ryk Is Required for Wnt5a-Mediated Axon Guidance on the Contralateral Side of the Corpus Callosum. J. Neurosci. 2006, 26, 5840-5848.
42. Orioli, D.; Henkemeyer, M.; Lemke, G.; Klein, R.; Pawson, T. Sek4 and Nuk Receptors Cooperate in Guidance of Commissural Axons and in Palate Formation. EMBO J. 1996, 15, 6035-6049.
43. Hock, B.; Bohme, B.; Karn, T.; Yamamoto, T.; Kaibuchi, K.; Holtrich, U.; Holland, S.; Pawson, T.; Rubsamen-Waigmann, H.; Strebhardt, K. PDZ-Domain-Mediated Interaction of the Eph-Related Receptor Tyrosine Kinase EphB3 and the Ras-Binding Protein AF6 Depends on the Kinase Activity of the Receptor. Proc. Natl. Acad. Sci. USA 1998, 95, 9779-9784.
44. Buchert, M.; Schneider, S.; Meskenaite, V.; Adams, M. T.; Canaani, E.; Baechi, T.; Moelling, K.; Hovens, C. M. The Junction-Associated Protein AF-6 Interacts and Clusters with Specific Eph Receptor Tyrosine Kinases at Specialized Sites of Cell-Cell Contact in the Brain. J. Cell Biol. 1999, 144, 361-371.
45. Patthy, L. The WIF Module. Trends Biochem. Sci. 2000, 25, 12-13.
46. Yoshikawa, S.; McKinnon, R. D.; Kokel, M.; Thomas, J. B. Wnt-Mediated Axon Guidance Via the Drosophila Derailed Receptor. Nature 2003, 422, 583-588.
47. Harris, K. E.; Beckendorf, S. K. Different Wnt Signals Act Through the Frizzled and RYK Receptors During Drosophila Salivary Gland Migration. Development 2007, 134, 2017-2025.
48. Grillenzoni, N.; Flandre, A.; Lasbleiz, C.; Dura, J. M. Respective Roles of the DRL Receptor and Its Ligand WNT5 in Drosophila Mushroom Body Development. Development 2007, 134, 3089-3097.
49. Yao, Y.; Wu, Y.; Yin, C.; Ozawa, R.; Aigaki, T.; Wouda, R. R.; Noordermeer, J. N.; Fradkin, L. G.; Hing, H. Antagonistic Roles of Wnt5 and the Drl Receptor in Patterning the Drosophila Antennal Lobe. Nat. Neurosci. 2007, 10, 1423-1432.
50. Fradkin, L. G.; van Schie, M.; Wouda, R. R.; de Jong, A.; Kamphorst, J. T.; Radjkoemar-Bansraj, M.; Noordermeer, J. N. The Drosophila Wnt5 Protein Mediates Selective Axon Fasciculation in the Embryonic Central Nervous System. Dev. Biol. 2004, 272, 362-375.
51. Deshpande, R.; Inoue, T.; Priess, J. R.; Hill, R. J. lin-17/Frizzled and lin-18 Regulate POP-1/TCF-1 Localization and Cell Type Specification During C. elegans Vulval Development. Dev. Biol. 2005, 278, 118-129.
52. Green, J. L.; Inoue, T.; Sternberg, P. W. The C. elegans ROR Receptor Tyrosine Kinase, CAM-1, Non-Autonomously Inhibits the Wnt Pathway. Development 2007, 134, 4053-4062.
53. Lu, W.; Yamamoto, V.; Ortega, B.; Baltimore, D. Mammalian Ryk Is a Wnt Coreceptor Required for Stimulation of Neurite Outgrowth. Cell 2004, 119, 97-108.
54. Liu, Y.; Shi, J.; Lu, C. C.; Wang, Z. B.; Lyuksyutova, A. I.; Song, X.; Zou, Y. Ryk-Mediated Wnt Repulsion Regulates Posterior-Directed Growth of Corticospinal Tract. Nat. Neurosci. 2005, 8, 1151-1159.
55. Schmitt, A. M.; Shi, J.; Wolf, A. M.; Lu, C. C.; King, L. A.; Zou, Y. Wnt-Ryk Signalling Mediates Medial-Lateral Retinotectal Topographic Mapping. Nature 2006, 439, 31-37.
56. Mikels, A. J.; Nusse, R. Purified Wnt5a Protein Activates or Inhibits Beta-Catenin-TCF Signaling Depending on Receptor Context. PLoS Biol. 2006, 4, e115.
57. Xu, Y. K.; Nusse, R. The Frizzled CRD Domain Is Conserved in Diverse Proteins Including Several Receptor Tyrosine Kinases. Curr. Biol. 1998, 8, R405-R406.
58. Masiakowski, P.; Yancopoulos, G. D. The Wnt Receptor CRD Domain Is Also Found in MuSK and Related Orphan Receptor Tyrosine Kinases. Curr. Biol. 1998, 8, R407.
59. Oishi, I.; Suzuki, H.; Onishi, N.; Takada, R.; Kani, S.; Ohkawara, B.; Koshida, I.; Suzuki, K.; Yamada, G.; Schwabe, G. C.; Mundlos, S.; Shibuya, H.; Takada, S.; Minami, Y. The Receptor Tyrosine Kinase Ror2 Is Involved in Non-Canonical Wnt5a/JNK Signalling Pathway. Genes Cells 2003, 8, 645-654.
60. Billiard, J.; Way, D. S.; Seestaller-Wehr, L. M.; Moran, R. A.; Mangine, A.; Bodine, P. V. The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells. Mol. Endocrinol. 2005, 19, 90-101.
61. Schambony, A.; Wedlich, D. Wnt-5A/Ror2 Regulate Expression of XPAPC Through an Alternative Noncanonical Signaling Pathway. Dev. Cell 2007, 12, 779-792.
62. MacLeod, R. J.; Hayes, M.; Pacheco, I. Wnt5a Secretion Stimulated by the Extracellular Calcium-Sensing Receptor Inhibits Defective Wnt Signaling in Colon Cancer Cells. Am. J. Physiol. 2007, 293, G403-G411.
63. Nishita, M.; Yoo, S. K.; Nomachi, A.; Kani, S.; Sougawa, N.; Ohta, Y.; Takada, S.; Kikuchi, A.; Minami, Y. Filopodia Formation Mediated by Receptor Tyrosine Kinase Ror2 Is Required for Wnt5a-Induced Cell Migration. J. Cell Biol. 2006, 175, 555-562.
64. Yamanaka, H.; Moriguchi, T.; Masuyama, N.; Kusakabe, M.; Hanafusa, H.; Takada, R.; Takada, S.; Nishida, E. JNK Functions in the Non-Canonical Wnt Pathway to Regulate Convergent Extension Movements in Vertebrates. EMBO Rep. 2002, 3, 69-75.
65. van Ooyen, A.; Nusse, R. Structure and Nucleotide Sequence of the Putative Mammary Oncogene int-1; Proviral Insertions Leave the Protein-Encoding Domain Intact. Cell 1984, 39, 233-240.
66. Nusse, R.; Varmus, H. E. Many Tumors Induced by the Mouse Mammary Tumor Virus Contain a Provirus Integrated in the Same Region of the Host Genome. Cell 1982, 31, 99-109.
67. Howe, L. R.; Brown, A. M. Wnt Signaling and Breast Cancer. Cancer Biol. Ther. 2004, 3, 36-41.
68. Weeraratna, A. T.; Jiang, Y.; Hostetter, G.; Rosenblatt, K.; Duray, P.; Bittner, M.; Trent, J. M. Wnt5a Signaling Directly Affects Cell Motility and Invasion of Metastatic Melanoma. Cancer Cell 2002, 1, 279-288.
69. Polakis, P. The Many Ways of Wnt in Cancer. Curr. Opin. Genet. Dev. 2007, 17, 45-51.
70. Giles, R. H.; van Es, J. H.; Clevers, H. Caught up in a Wnt Storm: Wnt Signaling in Cancer. Biochim. Biophys. Acta 2003, 1653, 1-24.
71. Segditsas, S.; Tomlinson, I. Colorectal Cancer and Genetic Alterations in the Wnt Pathway. Oncogene 2006, 25, 7531-7537.
72. Suzuki, H.; Gabrielson, E.; Chen, W.; Anbazhagan, R.; van Engeland, M.; Weijenberg, M. P.; Herman, J. G.; Baylin, S. B. A Genomic Screen for Genes Upregulated by Demethylation and Histone Deacetylase Inhibition in Human Colorectal Cancer. Nat. Genet. 2002, 31, 141-149.
73. Caldwell, G. M.; Jones, C.; Gensberg, K.; Jan, S.; Hardy, R. G.; Byrd, P.; Chughtai, S.; Wallis, Y.; Matthews, G. M.; Morton, D. G. The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis. Cancer Res. 2004, 64, 883-888.
74. Wissmann, C.; Wild, P. J.; Kaiser, S.; Roepcke, S.; Stoehr, R.; Woenckhaus, M.; Kristiansen, G.; Hsieh, J. C.; Hofstaedter, F.; Hartmann, A.; Knuechel, R.; Rosenthal, A.; Pilarsky, C. WIF1, a Component of the Wnt Pathway, Is Down-Regulated in Prostate, Breast, Lung, and Bladder Cancer. J. Pathol. 2003, 201, 204-212.
75. Mazieres, J.; He, B.; You, L.; Xu, Z.; Lee, A. Y.; Mikami, I.; Reguart, N.; Rosell, R.; McCormick, F.; Jablons, D. M. Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer. Cancer Res. 2004, 64, 4717-4720.
76. Niehrs, C. Function and Biological Roles of the Dickkopf Family of Wnt Modulators. Oncogene 2006, 25, 7469-7481.
77. Vibhakar, R.; Foltz, G.; Yoon, J. G.; Field, L.; Lee, H.; Ryu, G. Y.; Pierson, J.; Davidson, B.; Madan, A. Dickkopf-1 Is an Epigenetically Silenced Candidate Tumor Suppressor Gene in Medulloblastoma. Neuro Oncol. 2007, 9, 135-144.
78. Kuphal, S.; Lodermeyer, S.; Bataille, F.; Schuierer, M.; Hoang, B. H.; Bosserhoff, A. K. Expression of Dickkopf Genes Is Strongly Reduced in Malignant Melanoma. Oncogene 2006, 25, 5027-5036.
79. Roman-Gomez, J.; Jimenez-Velasco, A.; Agirre, X.; Castillejo, J. A.; Navarro, G.; Barrios, M.; Andreu, E. J.; Prosper, F.; Heiniger, A.; Torres, A. Transcriptional Silencing of the Dickkopfs-3 (Dkk-3) Gene by CpG Hypermethylation in Acute Lymphoblastic Leukaemia. Br. J. Cancer 2004, 91, 707-713.
80. Aguilera, O.; Fraga, M. F.; Ballestar, E.; Paz, M. F.; Herranz, M.; Espada, J.; Garcia, J. M.; Munoz, A.; Esteller, M.; Gonzalez-Sancho, J. M. Epigenetic Inactivation of the Wnt Antagonist DICKKOPF-1 (DKK-1) Gene in Human Colorectal Cancer. Oncogene 2006, 25, 4116-4121.
81. Wang, J.; Shou, J.; Chen, X. Dickkopf-1, an Inhibitor of the Wnt Signaling Pathway, Is Induced by p53. Oncogene 2000, 19, 1843-1848.
82. Cowling, V. H.; D'Cruz, C. M.; Chodosh, L. A.; Cole, M. D. c-Myc Transforms Human Mammary Epithelial Cells Through Repression of the Wnt Inhibitors DKK1 and SFRP1. Mol. Cell. Biol. 2007, 27, 5135-5146.
83. Maminta, M. L. D.; Williams, K. L.; Nakagawara, A.; Enger, K. T.; Guo, C.; Brodeur, G. M.; Deuel, T. F. Identification of a Novel Tyrosine Kinase Receptor-Like Molecule in Neuroblastomas. Biochem. Biophys. Res. Commun. 1992, 189, 1077-1083.
84. Muller-Tidow, C.; Schwable, J.; Steffen, B.; Tidow, N.; Brandt, B.; Becker, K.; Schulze-Bahr, E.; Halfter, H.; Vogt, U.; Metzger, R.; Schneider, P. M.; Buchner, T.; Brandts, C.; Berdel, W. E.; Serve, H. High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets. Clin. Cancer Res. 2004, 10, 1241-1249.
85. Leung, Y. K.; Gao, Y.; Lau, K. M.; Zhang, X.; Ho, S. M. ICI 182,780-Regulated Gene Expression in DU145 Prostate Cancer Cells Is Mediated by Estrogen Receptor-Beta/NFkappaB Crosstalk. Neoplasia 2006, 8, 242-249.
86. Katso, R. M.; Manek, S.; Biddolph, S.; Whittaker, R.; Charnock, M. F.; Wells, M.; Ganesan, T. S. Overexpression of H-Ryk in Mouse Fibroblasts Confers Transforming Ability In vitro and In vivo: Correlation with Up-Regulation in Epithelial Ovarian Cancer. Cancer Res. 1999, 59, 2265-2270.
87. Katso, R. M.; Manek, S.; Ganjavi, H.; Biddolph, S.; Charnock, M. F.; Bradburn, M.; Wells, M.; Ganesan, T. S. Overexpression of HRyk in Epithelial Ovarian Cancer: Prognostic Significance of Receptor Expression. Clin. Cancer Res. 2000, 6, 3271-3281.
88. Katoh, M.; Katoh, M. Comparative Genomics on ROR1 and ROR2 Orthologs. Oncol. Rep. 2005, 14, 1381-1384.
89. Claudio, J. O.; Zhan, F.; Zhuang, L.; Khaja, R.; Zhu, Y. X.; Sivananthan, K.; Trudel, S.; Masih-Khan, E.; Fonseca, R.; Bergsagel, P. L.; Scherer, S. W.; Shaughnessy, J.; Stewart, A. K. Expression and Mutation Status of Candidate Kinases in Multiple Myeloma. Leukemia 2007, 21, 1124-1127.
90. Oldridge, M.; Fortuna, A. M.; Maringa, M.; Propping, P.; Mansour, S.; Pollitt, C.; DeChiara, T. M.; Kimble, R. B.; Valenzuela, D. M.; Yancopoulos, G. D.; Wilkie, A. O. Dominant Mutations in ROR2, Encoding an Orphan Receptor Tyrosine Kinase, Cause Brachydactyly Type B. Nat. Genet. 2000, 24, 275-278.
91. Dale, T. C.; Weber-Hall, S. J.; Smith, K.; Huguet, E. L.; Jayatilake, H.; Gusterson, B. A.; Shuttleworth, G.; O'Hare, M.; Harris, A. L. Compartment Switching of WNT-2 Expression in Human Breast Tumors. Cancer Res. 1996, 56, 4320-4323.
92. Smith, K.; Bui, T. D.; Poulsom, R.; Kaklamanis, L.; Williams, G.; Harris, A. L. Up-Regulation of Macrophage Wnt Gene Expression in Adenoma-Carcinoma Progression of Human Colorectal Cancer. Br. J. Cancer 1999, 81, 496-502.
93. Bui, T. D.; Zhang, L.; Rees, M. C.; Bicknell, R.; Harris, A. L. Expression and Hormone Regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in Normal Human Endometrium and Endometrial Carcinoma. Br. J. Cancer 1997, 75, 1131-1136.
94. Rosner, A.; Miyoshi, K.; Landesman-Bollag, E.; Xu, X.; Seldin, D. C.; Moser, A. R.; MacLeod, C. L.; Shyamala, G.; Gillgrass, A. E.; Cardiff, R. D. Pathway Pathology: Histological Differences between ErbB/Ras and Wnt Pathway Transgenic Mammary Tumors. Am. J. Pathol. 2002, 161, 1087-1097.
95. Abu-Jawdeh, G.; Comella, N.; Tomita, Y.; Brown, L. F.; Tognazzi, K.; Sokol, S. Y.; Kocher, O. Differential Expression of FrpHE: A Novel Human Stromal Protein of the Secreted Frizzled Gene Family, During the Endometrial Cycle and Malignancy. Lab. Invest. 1999, 79, 439-447.
96. Joesting, M. S.; Perrin, S.; Elenbaas, B.; Fawell, S. E.; Rubin, J. S.; Franco, O. E.; Hayward, S. W.; Cunha, G. R.; Marker, P. C. Identification of SFRP1 as a Candidate Mediator of Stromal-to-Epithelial Signaling in Prostate Cancer. Cancer Res. 2005, 65, 10423-10430.
97. Giuliani, N.; Morandi, F.; Tagliaferri, S.; Lazzaretti, M.; Donofrio, G.; Bonomini, S.; Sala, R.; Mangoni, M.; Rizzoli, V. Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment. Cancer Res. 2007, 67, 7665-7674.
98. Lee, A. Y.; He, B.; You, L.; Xu, Z.; Mazieres, J.; Reguart, N.; Mikami, I.; Batra, S.; Jablons, D. M. Dickkopf-1 Antagonizes Wnt Signaling Independent of Beta-Catenin in Human Mesothelioma. Biochem. Biophys. Res. Commun. 2004, 323, 1246-1250.
99. Abarzua, F.; Sakaguchi, M.; Takaishi, M.; Nasu, Y.; Kurose, K.; Ebara, S.; Miyazaki, M.; Namba, M.; Kumon, H.; Huh, N. H. Adenovirus-Mediated Overexpression of REIC/Dkk-3 Selectively Induces Apoptosis in Human Prostate Cancer Cells Through Activation of c-Jun-NH2-Kinase. Cancer Res. 2005, 65, 9617-9622.
100. Peng, S.; Miao, C.; Li, J.; Fan, X.; Cao, Y.; Duan, E. Dickkopf-1 Induced Apoptosis in Human Placental Choriocarcinoma Is Independent of Canonical Wnt Signaling. Biochem. Biophys. Res. Commun. 2006, 350, 641-647.
101. Gonzalez-Sancho, J. M.; Aguilera, O.; Garcia, J. M.; Pendas-Franco, N.; Pena, C.; Cal, S.; Garcia de Herreros, A.; Bonilla, F.; Munoz, A. The Wnt Antagonist DICKKOPF-1 Gene Is a Downstream Target of Beta-Catenin/TCF and Is Downregulated in Human Colon Cancer. Oncogene 2005, 24, 1098-1103.
102. Sawyer, E. J.; Hanby, A. M.; Rowan, A. J.; Gillett, C. E.; Thomas, R. E.; Poulsom, R.; Lakhani, S. R.; Ellis, I. O.; Ellis, P.; Tomlinson, I. P. The Wnt Pathway, Epithelial-Stromal Interactions, and Malignant Progression in Phyllodes Tumours. J. Pathol. 2002, 196, 437-444.
103. Gunn, W. G.; Conley, A.; Deininger, L.; Olson, S. D.; Prockop, D. J.; Gregory, C. A. A Crosstalk between Myeloma Cells and Marrow Stromal Cells Stimulates Production of DKK1 and Interleukin-6: A Potential Role in the Development of Lytic Bone Disease and Tumor Progression in Multiple Myeloma. Stem Cells 2006, 24, 986-991.
104. Kobune, M.; Chiba, H.; Kato, J.; Kato, K.; Nakamura, K.; Kawano, Y.; Takada, K.; Takimoto, R.; Takayama, T.; Hamada, H.; Niitsu, Y. Wnt3/RhoA/ROCK Signaling Pathway Is Involved in Adhesion-Mediated Drug Resistance of Multiple Myeloma in an Autocrine Mechanism. Mol. Cancer Ther. 2007, 6, 1774-1784.
105. Wang, L.; O'Leary, H.; Fortney, J.; Gibson, L. F. Ph+/VECadherin+ Identifies a Stem Cell Like Population of Acute Lymphoblastic Leukemia Sustained by Bone Marrow Niche Cells. Blood 2007, 110, 3334-3344.
106. Masckauchan, T. N.; Kitajewski, J. Wnt/Frizzled Signaling in the Vasculature: New Angiogenic Factors in Sight. Physiology 2006, 21, 181-188.
107. Wright, M.; Aikawa, M.; Szeto, W.; Papkoff, J. Identification of a Wnt-Responsive Signal Transduction Pathway in Primary Endothelial Cells. Biochem. Biophys. Res. Commun. 1999, 263, 384-388.
108. Masckauchan, T. N.; Shawber, C. J.; Funahashi, Y.; Li, C. M.; Kitajewski, J. Wnt/Beta-Catenin Signaling Induces Proliferation, Survival and Interleukin-8 in Human Endothelial Cells. Angiogenesis 2005, 8, 43-51.
109. Goodwin, A. M.; Kitajewski, J.; D'Amore, P. A. Wnt1 and Wnt5a Affect Endothelial Proliferation and Capillary Length; Wnt2 Does Not. Growth Factors 2007, 25, 25-32.
110. Nimmagadda, S.; Geetha-Loganathan, P.; Scaal, M.; Christ, B.; Huang, R. FGFs, Wnts and BMPs Mediate Induction of VEGFR-2 (Quek-1) Expression During Avian Somite Development. Dev. Biol. 2007, 305, 421-429.
111. Adams, R. H.; Alitalo, K. Molecular Regulation of Angiogenesis and Lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8, 464-478.
112. Luu, H. H.; Zhang, R.; Haydon, R. C.; Rayburn, E.; Kang, Q.; Si, W.; Park, J. K.; Wang, H.; Peng, Y.; Jiang, W.; He, T. C. Wnt/Beta-Catenin Signaling Pathway as a Novel Cancer Drug Target. Curr. Cancer Drug Targets 2004, 4, 653-671.
113. Barker, N.; Clevers, H. Mining the Wnt Pathway for Cancer Therapeutics. Nat. Rev. Drug Discov. 2006, 5, 997-1014.
114. Zhou, L.; An, N.; Haydon, R. C.; Zhou, Q.; Cheng, H.; Peng, Y.; Jiang, W.; Luu, H. H.; Vanichakarn, P.; Szatkowski, J. P.; Park, J. Y.; Breyer, B.; He, T. C. Tyrosine Kinase Inhibitor STI-571/Gleevec Down-Regulates the Beta-Catenin Signaling Activity. Cancer Lett. 2003, 193, 161-170.
115. Shah, S.; Hecht, A.; Pestell, R.; Byers, S. W. Trans-Repression of Beta-Catenin Activity by Nuclear Receptors. J. Biol. Chem. 2003, 278, 48137-48145.
116. Shah, S.; Islam, M. N.; Dakshanamurthy, S.; Rizvi, I.; Rao, M.; Herrell, R.; Zinser, G.; Valrance, M.; Aranda, A.; Moras, D.; Norman, A.; Welsh, J.; Byers, S. W. The Molecular Basis of Vitamin D Receptor and Beta-Catenin Crossregulation. Mol. Cell 2006, 21, 799-809.
117. Boon, E. M.; Keller, J. J.; Wormhoudt, T. A.; Giardiello, F. M.; Offerhaus, G. J.; van der Neut, R.; Pals, S. T. Sulindac Targets Nuclear Beta-Catenin Accumulation and Wnt Signalling in Adenomas of Patients with Familial Adenomatous Polyposis and in Human Colorectal Cancer Cell Lines. Br. J. Cancer 2004, 90, 224-229.
118. s-Axin-Beta-Catenin Signaling Axis. Science 2005, 310, 1504-1510.
119. Lepourcelet, M.; Chen, Y. N.; France, D. S.; Wang, H.; Crews, P.; Petersen, F.; Bruseo, C.; Wood, A. W.; Shivdasani, R. A. Small-Molecule Antagonists of the Oncogenic Tcf/Beta-Catenin Protein Complex. Cancer Cell 2004, 5, 91-102.
120. Emami, K. H.; Nguyen, C.; Ma, H.; Kim, D. H.; Jeong, K. W.; Eguchi, M.; Moon, R. T.; Teo, J. L.; Kim, H. Y.; Moon, S. H.; Ha, J. R.; Kahn, M. A Small Molecule Inhibitor of Beta-Catenin/CREB-Binding Protein Transcription. Proc. Natl. Acad. Sci. USA 2004, 101, 12682-12687.
121. Whittaker, S. R.; Walton, M. I.; Garrett, M. D.; Workman, P. The Cyclin-Dependent Kinase Inhibitor Cyc202 (R-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-Activated Protein Kinase Pathway. Cancer Res. 2004, 64, 262-272.
122. Shan, J.; Shi, D. L.; Wang, J.; Zheng, J. Identification of a Specific Inhibitor of the Dishevelled PDZ Domain. Biochemistry 2005, 44, 15495-15503.
123. Satoh, S.; Daigo, Y.; Furukawa, Y.; Kato, T.; Miwa, N.; Nishiwaki, T.; Kawasoe, T.; Ishiguro, H.; Fujita, M.; Tokino, T.; Sasaki, Y.; Imaoka, S.; Murata, M.; Shimano, T.; Yamaoka, Y.; Nakamura, Y. AXIN1 Mutations in Hepatocellular Carcinomas, and Growth Suppression in Cancer Cells by Virus-Mediated Transfer of AXIN1. Nat. Genet. 2000, 24, 245-250.
124. Shih, I. M.; Yu, J.; He, T. C.; Vogelstein, B.; Kinzler, K. W. The Beta-Catenin Binding Domain of Adenomatous Polyposis Coli Is Sufficient for Tumor Suppression. Cancer Res. 2000, 60, 1671-1676.
125. Roh, H.; Green, D. W.; Boswell, C. B.; Pippin, J. A.; Drebin, J. A. Suppression of Beta-Catenin Inhibits the Neoplastic Growth of APC-Mutant Colon Cancer Cells. Cancer Res. 2001, 61, 6563-6568.
126. Verma, U. N.; Surabhi, R. M.; Schmaltieg, A.; Becerra, C.; Gaynor, R. B. Small Interfering RNAs Directed against Beta-Catenin Inhibit the In vitro and In vivo Growth of Colon Cancer Cells. Clin. Cancer Res. 2003, 9, 1291-1300.
127. Iversen, P. L.; Arora, V.; Acker, A. J.; Mason, D. H.; Devi, G. R. Efficacy of Antisense Morpholino Oligomer Targeted to c-Myc in Prostate Cancer Xenograft Murine Model and a Phase I Safety Study in Humans. Clin. Cancer Res. 2003, 9, 2510-2519.
128. Lipinski, K. S.; Djeha, H. A.; Gawn, J.; Cliffe, S.; Maitland, N. J.; Palmer, D. H.; Mountain, A.; Irvine, A. S.; Wrighton, C. J. Optimization of a Synthetic Beta-Catenin-Dependent Promoter for Tumor-Specific Cancer Gene Therapy. Mol. Ther. 2004, 10, 150-161.
129. Kuhnert, F.; Davis, C. R.; Wang, H. T.; Chu, P.; Lee, M.; Yuan, J.; Nusse, R.; Kuo, C. J. Essential Requirement for Wnt Signaling in Proliferation of Adult Small Intestine and Colon Revealed by Adenoviral Expression of Dickkopf-1. Proc. Natl. Acad. Sci. USA 2004, 101, 266-271.
130. He, B.; You, L.; Uematsu, K.; Xu, Z.; Lee, A. Y.; Matsangou, M.; McCormick, F.; Jablons, D. M. A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells. Neoplasia 2004, 6, 7-14.
131. He, B.; Reguart, N.; You, L.; Mazieres, J.; Xu, Z.; Lee, A. Y.; Mikami, I.; McCormick, F.; Jablons, D. M. Blockade of Wnt-1 Signaling Induces Apoptosis in Human Colorectal Cancer Cells Containing Downstream Mutations. Oncogene 2005, 24, 3054-3058.
132. You, L.; He, B.; Xu, Z.; Uematsu, K.; Mazieres, J.; Fujii, N.; Mikami, I.; Reguart, N.; McIntosh, J. K.; Kashani-Sabet, M.; McCormick, F.; Jablons, D. M. An Anti-Wnt-2 Monoclonal Antibody Induces Apoptosis in Malignant Melanoma Cells and Inhibits Tumor Growth. Cancer Res. 2004, 64, 5385-5389.
133. Mikami, I.; You, L.; He, B.; Xu, Z.; Batra, S.; Lee, A. Y.; Mazieres, J.; Reguart, N.; Uematsu, K.; Koizumi, K.; Jablons, D. M. Efficacy of Wnt-1 Monoclonal Antibody in Sarcoma Cells. BMC Cancer 2005, 5, 53.
134. Mazieres, J.; You, L.; He, B.; Xu, Z.; Lee, A. Y.; Mikami, I.; McCormick, F.; Jablons, D. M. Inhibition of Wnt16 in Human Acute Lymphoblastoid Leukemia Cells Containing the t(1;19) Translocation Induces Apoptosis. Oncogene 2005, 24, 5396-5400.
135. Mazieres, J.; You, L.; He, B.; Xu, Z.; Twogood, S.; Lee, A. Y.; Reguart, N.; Batra, S.; Mikami, I.; Jablons, D. M. Wnt2 as a New Therapeutic Target in Malignant Pleural Mesothelioma. Int. J. Cancer 2005, 117, 326-332.
136. Shi, Y.; He, B.; Kuchenbecker, K. M.; You, L.; Xu, Z.; Mikami, I.; Yagui-Beltran, A.; Clement, G.; Lin, Y. C.; Okamoto, J.; Bravo, D. T.; Jablons, D. M. Inhibition of Wnt-2 and Galectin-3 Synergistically Destabilizes Beta-Catenin and Induces Apoptosis in Human Colorectal Cancer Cells. Int. J. Cancer 2007, 121, 1175-1181.